Calcium Channel Blockers: One Class, Two Very Different Jobs
Two drugs, both called 'calcium channel blockers,' can do almost opposite things: one relaxes your arteries and leaves your heart alone, the other slows your heart and calms its rhythm. Mix them up and you can dangerously stall a heart — or fail to control an arrhythmia. The split comes down to a single question: does the drug prefer the blood vessels, or the heart itself?
A woman started on amlodipine for high blood pressure comes back worried: her ankles have puffed up, and she's convinced her heart is failing. But her heart is fine — the swelling is a direct effect of her blood-pressure pill, which relaxes the small arteries so effectively that fluid leaks into her ankles. Reassured, she keeps taking it. Her drug acts almost entirely on the vessels. Its cousins, verapamil and diltiazem, would instead have slowed her heart. Same channel blocked, two different targets — that's the whole story.
How they work — and the great divide
They block calcium entry — but in different places. Calcium channel blockers block the L-type calcium channels that let calcium into muscle cells. Calcium makes both the heart contract and the arteries constrict, so blocking it relaxes vessels and weakens/slows the heart. The class splits into two families by which of these they prefer. The dihydropyridines (the '-dipines': amlodipine, nifedipine, felodipine) act almost only on the ARTERIES — powerful vasodilators that lower blood pressure with little direct effect on the heart. The non-dihydropyridines (verapamil and diltiazem) act more on the HEART — slowing the heart rate, slowing conduction through the AV node, and reducing the force of contraction. One relaxes pipes; the other calms the pump.
The dihydropyridines: vessel relaxers
The '-dipines' are excellent, safe blood-pressure drugs — amlodipine is one of the most prescribed in the world — and are first-line for hypertension, especially in older and Black patients. They also treat angina (by widening coronary and other arteries) and Raynaud's phenomenon. Their side effects flow straight from vasodilation: ankle swelling (peripheral oedema, as in our patient), flushing, and headache. A note on speed: long-acting amlodipine is smooth and safe, but SHORT-acting nifedipine drops pressure so fast that the baroreceptor reflex fires back with a racing heart, so the immediate-release form is avoided.
Verapamil & diltiazem: heart slowers
Because verapamil and diltiazem act on the heart, they're used not only for blood pressure and angina but to CONTROL THE RATE in fast rhythms like atrial fibrillation and other supraventricular tachycardias — they slow conduction through the AV node. Their side effects mirror that cardiac action: an overly slow heart (bradycardia) and heart block, and worsening of heart failure because they weaken contraction. Verapamil is also a classic cause of constipation. And a crucial safety rule: don't combine verapamil or diltiazem with a beta blocker, because both slow the AV node — together they can cause dangerous bradycardia or complete heart block.
- CCBs block L-type calcium channels, relaxing vessels and slowing/weakening the heart.
- Dihydropyridines (-dipine) act on ARTERIES → lower BP; side effect: ankle edema, flushing.
- Verapamil & diltiazem act on the HEART → slow rate & AV conduction (rate control in AF).
- Don't combine verapamil/diltiazem with a beta blocker — risk of severe bradycardia/heart block.
- Verapamil causes constipation; avoid non-dihydropyridines in heart failure.
Match the calcium channel blocker to the goal. Want to lower blood pressure and leave the heart alone? Reach for a dihydropyridine like amlodipine. Want to slow a racing heart or control atrial fibrillation? Reach for verapamil or diltiazem. Get this backwards — giving a heart-slowing verapamil to someone already on a beta blocker, or expecting amlodipine to control a fast rhythm — and you either stall the heart or fail to fix the arrhythmia. Vessels versus pump is the question to ask every time.
- Mistaking amlodipine's ankle edema for heart failure. It's harmless vasodilation.
- Combining verapamil/diltiazem with a beta blocker. Risk of severe bradycardia or heart block.
- Using verapamil or diltiazem in significant heart failure. They weaken contraction.
- Prescribing short-acting nifedipine for chronic BP. It causes reflex tachycardia — use long-acting.
Which calcium channel blocker is best for controlling the heart rate in atrial fibrillation?
- CCBs block L-type calcium channels — relaxing vessels and/or slowing the heart.
- Dihydropyridines (-dipine) → arteries → lower BP; side effect: ankle edema.
- Verapamil & diltiazem → heart → slow rate & AV conduction (rate control in AF).
- Don't combine verapamil/diltiazem with a beta blocker; avoid them in heart failure.
- Katzung BG. Basic & Clinical Pharmacology — Calcium channel blockers (vascular selective vs cardiac).
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Calcium channel antagonists.
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — Calcium antagonists.
- ACC/AHA & ESC guidelines — Calcium channel blockers in hypertension, angina & rate control.
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Calcium channel blockers.
